9 March 2026
GENETIC PREDISPOSITIONS IN BRAIN TUMORS
It is with great pleasure that I announce the second video conference of 2026, where we will discuss Genetic Predispositions…
Author: Roberto Pugliese (Admin)
18 February 2026
VIDEO CONFERENCE “PNEI AND TUMORS: ANTI-CANCER MOLECULES IN THE HUMAN BODY”
The video conference dedicated to Psychoneuroendocrinoimmunology (PNEI) and the role of molecules produced by our body in the fight against…
GLIOBLASTOMA: NEW THERAPEUTIC FRONTIERS BETWEEN NANOTECHNOLOGY, STEM CELLS, AND THE IMMUNE SYSTEM
Next week will be packed with events to disseminate information on the treatment of glioblastoma and high-grade brain tumors. As…
PNEI AND TUMORS: THE HUMAN BODY’S ANTI-CANCER MOLECULES
It is with great pleasure that I announce the first video conference of 2026, where we will discuss Psycho-Neuro-Endocrine-Immunology (PNEI)…
MIRAGE Study: A Possible New Path for More Aggressive Meningiomas
Among tumors that develop inside the skull, meningioma is one of the most common. Unlike other brain tumors, it does not arise…
THE STORY OF FRANCESCO DAMIANO AND HIS IMMENSE LOVE FOR LIFE
In recent months, I’ve spoken a few times with Eugenio, Ciccio’s father. He entrusted me with their story, and I…
20 January 2026
Research News in the Last Two-Months of 2025
This is the thirty-fourth article of a project whose aim is to periodically collect (every two months) the latest research…
THE GALAXY THAT KEEPS THE LIGHT ON
When you enter the world of a brain tumor, you often feel as if you have been catapulted into an…
THE LIGHT THAT REMAINS LIT
During these holidays, a Christmas tree is lit in my house. The lights are soft, warm, and next to them…
19 December 2025
NEW PHASE 3 CLINICAL TRIAL FOR GLIOBLASTOMA: OPTUNE®, TEMOZOLOMIDE, AND PEMBROLIZUMAB
Continuing with the idea of reporting to you some interesting clinical studies in the recruitment phase as we did in…
